← Back to Clinical Trials
Recruiting NCT07150143

NCT07150143 Effects of Connective Tissue Massage and Physical Modalities Combined With Stabilization Exercises in Chronic Neck Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07150143
Status Recruiting
Phase
Sponsor Fenerbahce University
Condition Non-specific Neck Pain
Study Type INTERVENTIONAL
Enrollment 27 participants
Start Date 2025-09-12
Primary Completion 2025-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
ExerciseConnective tissue massageInfrared therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 27 participants in total. It began in 2025-09-12 with a primary completion date of 2025-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized, double-blinded controlled trial aims to investigate the comparative effects of connective tissue massage and physical modalities, when combined with cervical and scapulothoracic stabilization exercises, in individuals with chronic non-specific neck pain. A total of 51 participants aged 18-65 years will be randomly assigned into three groups. Group 1 will perform stabilization exercises alone, Group 2 will receive stabilization exercises plus connective tissue massage, and Group 3 will receive stabilization exercises plus electrotherapy modalities (infrared, continuous ultrasound, and TENS). The interventions will be conducted twice weekly for 8 weeks, and participants will also perform home-based exercises daily. Primary outcomes include pain, disability, and endurance, while secondary outcomes focus on quality of life, cervical range of motion, and scapular function.

Eligibility Criteria

Inclusion Criteria: * Being between 18 and 65 years of age, * Having non-specific chronic neck pain localized to the posterior cervical spine between the occipital region and the spinous process of the first thoracic vertebra, * Being able to cooperate with the assessments to be performed in the study. Exclusion Criteria: * Neck pain resulting from trauma within the past 6 months; * A history of surgery related to cervical problems; * Clinical signs of cervical radiculopathy and/or myelopathy; * Inflammatory arthritis involving the cervical spine; * Tumors or infections of the cervical spine; * Vertebrobasilar artery insufficiency; * Neurological disorders (such as multiple sclerosis, Parkinson's disease, or syringomyelia); * Congenital anomalies affecting the spine; systemic diseases (such as diabetes mellitus); * Shoulder pathologies (including tendinitis, bursitis, or capsulitis).

Contact & Investigator

Central Contact

Burcu AKKURT, PhD

✉ burcu.akkurt@fbu.edu.tr

📞 +905536046713

Principal Investigator

Burcu AKKURT, PhD

STUDY DIRECTOR

Fenerbahçe University

Frequently Asked Questions

Who can join the NCT07150143 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Non-specific Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07150143 currently recruiting?

Yes, NCT07150143 is actively recruiting participants. Contact the research team at burcu.akkurt@fbu.edu.tr for enrollment information.

Where is the NCT07150143 trial being conducted?

This trial is being conducted at Ataşehir, Turkey (Türkiye).

Who is sponsoring the NCT07150143 clinical trial?

NCT07150143 is sponsored by Fenerbahce University. The principal investigator is Burcu AKKURT, PhD at Fenerbahçe University. The trial plans to enroll 27 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology